Universal stool donor model for FMT improves screening, reduces costs, delays

Study data show the need for evidence-based stool screening standards, and the usefulness of the universal donor model for fecal microbiota transplantation therapy for recurrent Clostridium difficile infection, according to a distinguished abstract presented at Digestive Disease Week.“Where do we find these supremely healthy donors, and how do we know who is eligible to be a fecal transplant donor?” Laura J. Burns, from OpenBiome, an international public stool bank in Medford, Massachusetts, said in her presentation. “We have a three-step approach to recruiting and determining the eligibility of our donors.”